Gudmundur Johannsson
Gudmundur Johannsson
Institute of Medicine, Sahlgrenska Academy, University of Gothenburg
Verifierad e-postadress på gu.se
Titel
Citeras av
Citeras av
År
Treatment of acromegaly with the growth hormone–receptor antagonist pegvisomant
PJ Trainer, WM Drake, L Katznelson, PU Freda, V Herman-Bonert, ...
New England Journal of Medicine 342 (16), 1171-1177, 2000
8942000
Long-term treatment of acromegaly with pegvisomant, a growth hormone receptor antagonist
AJ van der Lely, RK Hutson, PJ Trainer, GM Besser, AL Barkan, ...
The Lancet 358 (9295), 1754-1759, 2001
6972001
Management of the child born small for gestational age through to adulthood: a consensus statement of the International Societies of Pediatric Endocrinology and the Growth …
PE Clayton, S Cianfarani, P Czernichow, G Johannsson, R Rapaport, ...
The Journal of Clinical Endocrinology & Metabolism 92 (3), 804-810, 2007
6302007
Growth hormone treatment of abdominally obese men reduces abdominal fat mass, improves glucose and lipoprotein metabolism, and reduces diastolic blood pressure
G Johannsson, P Mårin, L Lönn, M Ottosson, K Stenlöf, P Björntorp, ...
The Journal of Clinical Endocrinology & Metabolism 82 (3), 727-734, 1997
5471997
Premature mortality in patients with Addison’s disease: a population-based study
R Bergthorsdottir, M Leonsson-Zachrisson, A Odén, G Johannsson
The Journal of Clinical Endocrinology & Metabolism 91 (12), 4849-4853, 2006
4582006
Estrogen regulation of growth hormone action
KC Leung, G Johannsson, GM Leong, KKY Ho
Endocrine reviews 25 (5), 693-721, 2004
4582004
Consensus guidelines for the diagnosis and treatment of adults with GH deficiency II: a statement of the GH Research Society in association with the European Society for …
KK Ho
European Journal of Endocrinology 157 (6), 695-700, 2007
4212007
Two years of growth hormone (GH) treatment increases bone mineral content and density in hypopituitary patients with adult-onset GH deficiency
G Johannsson, T Rosen, I Bosaeus, L Sjöström, BÅ Bengtsson
The Journal of Clinical Endocrinology & Metabolism 81 (8), 2865-2873, 1996
2851996
The impact of glucocorticoid replacement regimens on metabolic outcome and comorbidity in hypopituitary patients
H Filipsson, JP Monson, M Koltowska-Häggström, A Mattsson, ...
The Journal of Clinical Endocrinology & Metabolism 91 (10), 3954-3961, 2006
2802006
Role of the GH/IGF-1 axis in lifespan and healthspan: lessons from animal models
DE Berryman, JS Christiansen, G Johannsson, MO Thorner, JJ Kopchick
Growth Hormone & IGF Research 18 (6), 455-471, 2008
2662008
Improved cortisol exposure-time profile and outcome in patients with adrenal insufficiency: a prospective randomized trial of a novel hydrocortisone dual-release formulation
G Johannsson, AG Nilsson, R Bergthorsdottir, P Burman, P Dahlqvist, ...
The Journal of Clinical Endocrinology & Metabolism 97 (2), 473-481, 2012
2542012
Malignant disease and cardiovascular morbidity in hypopituitary adults with or without growth hormone replacement therapy
J Svensson, BA Bengtsson, T Rosen, A Oden, G Johannsson
The Journal of Clinical Endocrinology & Metabolism 89 (7), 3306-3312, 2004
2432004
The individual responsiveness to growth hormone (GH) treatment in GH-deficient adults is dependent on the level of GH-binding protein, body mass index, age, and gender.
G Johannsson, R Bjarnason, M Bramnert, LM Carlsson, M Degerblad, ...
The Journal of Clinical Endocrinology & Metabolism 81 (4), 1575-1581, 1996
2291996
Growth Hormone Research Society workshop summary: consensus guidelines for recombinant human growth hormone therapy in Prader-Willi syndrome
CL Deal, M Tony, C Höybye, DB Allen, M Tauber, JS Christiansen, ...
The Journal of Clinical Endocrinology & Metabolism 98 (6), E1072-E1087, 2013
2042013
Low dose dehydroepiandrosterone affects behavior in hypopituitary androgen-deficient women: a placebo-controlled trial
G Johannsson, P Burman, L Wirén, BE Engström, AG Nilsson, ...
The Journal of Clinical Endocrinology & Metabolism 87 (5), 2046-2052, 2002
2032002
Individualized dose titration of growth hormone (GH) during GH replacement in hypopituitary adults
G Johannsson, T Rosén, BÅ Bengtsson
Clinical Endocrinology 47 (5), 571-581, 1997
1961997
Two years of growth hormone (GH) treatment increase isometric and isokinetic muscle strength in GH-deficient adults
G Johannsson, G Grimby, KS Sunnerhagen, BA Bengtsson
The Journal of Clinical Endocrinology & Metabolism 82 (9), 2877-2884, 1997
1911997
Discontinuation of growth hormone (GH) treatment: metabolic effects in GH-deficient and GH-sufficient adolescent patients compared with control subjects
G Johannsson, K Albertsson-Wikland, ...
The Journal of Clinical Endocrinology & Metabolism 84 (12), 4516-4524, 1999
1851999
A prospective study of 5 years of GH replacement therapy in GH-deficient adults: sustained effects on body composition, bone mass, and metabolic indices
G Gotherstrom, J Svensson, J Koranyi, M Alpsten, I Bosaeus, ...
The Journal of Clinical Endocrinology & Metabolism 86 (10), 4657-4665, 2001
1742001
Growth hormone treatment reduces abdominal visceral fat in postmenopausal women with abdominal obesity: a 12-month placebo-controlled trial
C Franco, J Brandberg, L Lönn, B Andersson, BA Bengtsson, ...
The Journal of Clinical Endocrinology & Metabolism 90 (3), 1466-1474, 2005
1632005
Systemet kan inte utföra åtgärden just nu. Försök igen senare.
Artiklar 1–20